BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32452582)

  • 41. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and functional characterization of an organometallic ruthenium complex as a potential myorelaxant drug.
    Trobec T; Žužek MC; Sepčić K; Kladnik J; Kljun J; Turel I; Benoit E; Frangež R
    Biomed Pharmacother; 2020 Jul; 127():110161. PubMed ID: 32380389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
    Ma W; Bi J; Zhao C; Gao Y; Zhang G
    Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition effects of isoproterenol, chlorpromazine, carbamazepine, tamoxifen drugs on glutathione S-transferase, cholinesterases enzymes and molecular docking studies.
    Türkan F; Calimli MH; Kanberoğlu GS; Karaman M
    J Biomol Struct Dyn; 2021 Jun; 39(9):3277-3284. PubMed ID: 32362189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
    Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
    Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
    Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
    Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scandium triflate-catalyzed one-pot domino approach towards general and efficient syntheses of unsymmetrical 9-substituted xanthene derivatives.
    Singh R; Panda G
    Org Biomol Chem; 2010 Mar; 8(5):1097-105. PubMed ID: 20165800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
    Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
    Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and
    Bortolami M; Pandolfi F; Tudino V; Messore A; Madia VN; De Vita D; Di Santo R; Costi R; Romeo I; Alcaro S; Colone M; Stringaro A; Espargaró A; Sabatè R; Scipione L
    ACS Chem Neurosci; 2021 Nov; 12(21):4090-4112. PubMed ID: 34652128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors.
    Ekiz M; Tutar A; Ökten S; Bütün B; Koçyiğit ÜM; Taslimi P; Topçu G
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800167. PubMed ID: 30079554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
    Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
    Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.